Moderna rises as CDC expands RSV vaccine guidance to include high-risk adults aged 50-59, boosting mResvia's reach.

Moderna stock popped Wednesday after the CDC recommended the company's RSV vaccine for at-risk adults in their 50s.

Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...

Good morning, it’s the third of July. This newsletter will be off tomorrow for the holiday and — surprise — all of next week.

Vaccine supply shortage comes at a bad time, as African countries make headway with their outbreaks and have seen good uptake ...

Cambodia's health ministry today announced another human H5N1 avian flu case of the year, involving a 5-year-old boy from ...

共有六家中国制药企业进入了全球药企50强。其中，云南白药排名第33位，中国生物制药排名第39位，华东医药排名第41位，百济神州排名第44位，江苏恒瑞医药排名第46位，石药集团排名第48位。